THB Asset Management’s Haemonetics HAE Stock Holding History

THB Asset Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-80,900	Closed	-$3.35M	–	211
2015 Q2	$3.35M	Sell	80,900 -48,421	-37%	-$2.04M	0.25%	139
2015 Q1	$5.81M	Buy	129,321 +62,597	+94%	+$2.62M	0.41%	101
2014 Q4	$2.5M	Buy	66,724 +20,744	+45%	+$760K	0.17%	174
2014 Q3	$1.6M	Buy	+45,980	New	+$1.64M	0.11%	198
2013 Q3	–	Sell	-61,770	Closed	-$2.55M	–	267
2013 Q2	$2.55M	Buy	+61,770	New	+$2.5M	0.17%	185

Other funds holding HAE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

THB Asset Management's HAE Position: Q3 2015 in Review

THB Asset Management sold out of Haemonetics (HAE) in Q3 2015, closing a stake of 80,900 shares — an estimated $3.35M sold.

THB Asset Management first reported a position in HAE in Q2 2013 and held it in 5 quarters. The position peaked at $5.81M in Q1 2015. 172 funds tracked by Wall St. Rank hold HAE as of Q3 2015.

THB Asset Management reported no remaining Haemonetics position as of Q3 2015 after selling out during the quarter.
THB Asset Management sold 80,900 Haemonetics shares in Q3 2015, an estimated $3.35M.
THB Asset Management first reported a position in Haemonetics in Q2 2013 and held it in 5 quarters.
THB Asset Management's Haemonetics position peaked at $5.81M in Q1 2015.
172 funds tracked by Wall St. Rank held Haemonetics as of Q3 2015.

Based on THB Asset Management's 13F filing for Q3 2015, filed 16 Oct 2015.